Methylphenidate Efficacy: Immediate versus Extended Release at Short Term in Mexican Children with ADHD Assessed by Conners Scale and EEG
Neurology Research International · 2015 · 2015 · 1-9
DOI: 10.1155/2015/207801 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurology Research International, 2015. Verfasst von Alfredo Durand-Rivera und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Neuroprotección, Servicio de Neurorrehabilitación, Instituto Nacional de Rehabilitación, 14389 México, DF, Mexico ; Centro de Atención…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Psicofarma S.A. de C.V..
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Attention deficit hyperactivity disorder (ADHD) affects 5-6% of school aged children worldwide. Pharmacological therapy is considered the first-line treatment and methylphenidate (MPH) is considered the first-choice medication. There are two formulations: immediate release (IR) MPH and long-acting (or extended release) formulation (MPH-ER). In this work, we measure the efficacy of treatment for both presentations in one month with Conners’ scales and electroencephalography (EEG). Results . for IR group, in parents and teachers Conners test, all items showed significant differences, towards improvement, except for teachers in perfectionism and emotional instability. For ER group in parent’s Conners test, the items in which there were no significant differences are psychosomatic and emotional instability. For teachers, there were no significant differences in: hyperactivity and perfectionism. Comparing the Conners questionnaires (parents versus teachers) we find significant differences before and after treatment in hyperactivity, perfectionism, psychosomatics, DSM-IV hyperactive-impulsive, and DSM-IV total. In the EEG the Wilcoxon test showed a significant difference ( P < 0.0001 ) . As we can see, both presentations are suitable for managing the ADHD and have the same effect on the symptomatology and in the EEG.
Autor:innen und Institutionen
- Laboratorio de Neuroprotección, Servicio de Neurorrehabilitación, Instituto Nacional de Rehabilitación, 14389 México, DF, Mexico ; Centro de Atención Médica y Educación Especial, 14370 México, DF, Mexico.
- Laboratorio de Neuroprotección, Servicio de Neurorrehabilitación, Instituto Nacional de Rehabilitación, 14389 México, DF, Mexico.
- Laboratorio de Neurofisiología Cognitiva, Instituto Nacional de Rehabilitación, 14389 México, DF, Mexico.
ORCID-Profile: Alfredo Durand-Rivera
Förderung
- Psicofarma S.A. de C.V.
Zitieren
APA
Durand-Rivera, A., Alatorre-Miguel, E., Zambrano-Sánchez, E., & Reyes-Legorreta, C. (2015). Methylphenidate Efficacy: Immediate versus Extended Release at Short Term in Mexican Children with ADHD Assessed by Conners Scale and EEG. Neurology Research International, 2015, 1-9. https://doi.org/10.1155/2015/207801
Vancouver
Durand-Rivera A, Alatorre-Miguel E, Zambrano-Sánchez E, Reyes-Legorreta C. Methylphenidate Efficacy: Immediate versus Extended Release at Short Term in Mexican Children with ADHD Assessed by Conners Scale and EEG. Neurology Research International. 2015;2015:1-9. doi:10.1155/2015/207801
BibTeX
@article{DurandRivera2015,
author = {Durand-Rivera, Alfredo and Alatorre-Miguel, Efren and Zambrano-Sánchez, Elizabeth and Reyes-Legorreta, Celia},
title = {Methylphenidate Efficacy: Immediate versus Extended Release at Short Term in Mexican Children with ADHD Assessed by Conners Scale and EEG},
journal = {Neurology Research International},
year = {2015},
volume = {2015},
pages = {1--9},
doi = {10.1155/2015/207801}
}
EUVIMED